We are live on ! Find out more
FSTX

F-star Therapeutics, Inc. Common Stock
FSTX

Delisted

FSTX was delisted on the 8th of March, 2023.

Back to rankings

31 hedge funds and large institutions have $5.59M invested in F-star Therapeutics, Inc. Common Stock in 2019 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 12 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

23% less funds holding

Funds holding: 40 → 31 (-9)

58% less repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 12

75% less capital invested

Capital invested by funds: $22.3M → $5.59M (-$16.7M)

82% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 11

Holders
31
Holders Change
-9
Holders Change %
-22.5%
% of All Funds
0.61%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
5
Reduced
12
Closed
11
Calls
$316K
Puts
–
Net Calls
+$316K
Net Calls Change
-$372K

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$162K
2
Citadel Advisors
Citadel Advisors
Florida
+$36.9K
3
AIM
Alambic Investment Management
California
+$32.1K
4
BlackRock
BlackRock
New York
+$20K
5
Morgan Stanley
Morgan Stanley
New York
+$9.67K

Top Sellers

Rank Fund Capital Flow
1
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$4.9M
2
BI
BVF Inc
California
-$1.36M
3
Axa
Axa
France
-$1.3M
4
SAM
Sectoral Asset Management
Quebec, Canada
-$952K
5
PCM
Parsons Capital Management
Rhode Island
-$577K
Name Holding Trade Value Shares
Change 		Change in
Stake
GT
26
Glenmede Trust
Pennsylvania
$6K – – –
MAM
27
Meeder Asset Management
Ohio
$4K – – –
Royal Bank of Canada
28
Royal Bank of Canada
Ontario, Canada
$3K – – –
UBS Group
29
UBS Group
Switzerland
$1K -$5.91K -465 -79%
BNP Paribas Financial Markets
30
BNP Paribas Financial Markets
France
$122 -$4.88K -384 -95%
Adage Capital Partners
31
Adage Capital Partners
Massachusetts
– -$4.9M -356,250 Closed
Axa
32
Axa
France
– -$1.3M -94,545 Closed
SAM
33
Sectoral Asset Management
Quebec, Canada
– -$952K -69,164 Closed
PP
34
Paloma Partners
Connecticut
– -$157K -11,182 Closed
MAM
35
Morse Asset Management
Connecticut
– -$148K -10,734 Closed
CC
36
Caxton Corporation
New Jersey
– -$82K -5,969 Closed
State Street
37
State Street
Massachusetts
– -$46K -3,280 Closed
LP
38
LMR Partners
United Kingdom
– -$40K -2,855 Closed
Victory Capital Management
39
Victory Capital Management
Texas
– -$10K -703 Closed
Citigroup
40
Citigroup
New York
– -$5K -391 Closed
Bank of America
41
Bank of America
North Carolina
– -$2K -166 Closed
Deutsche Bank
42
Deutsche Bank
Germany
– -$140 -11 -44%
1
2

FSTX Hedge Fund Activity: Q4 2019 in Review

31 of the 5,076 institutional investors tracked by Wall St. Rank reported a position in F-star Therapeutics, Inc. Common Stock (FSTX) for Q4 2019, worth a combined $5.59M — down 75% from $22.3M a quarter earlier.

Sellers outnumbered buyers: 11 funds closed out of FSTX and 2 opened new positions — a net loss of 9 holders — while 12 trimmed existing stakes and 5 added.

The largest buyer was Renaissance Technologies, adding an estimated $162K. The largest seller was Adage Capital Partners, exiting entirely with an estimated $4.9M sold.

  • 31 institutional investors held F-star Therapeutics, Inc. Common Stock (FSTX) as of Q4 2019, down from 40 in Q3 2019.
  • Funds reported $5.59M of F-star Therapeutics, Inc. Common Stock stock for Q4 2019, down 75% quarter-over-quarter.
  • 2 funds opened new F-star Therapeutics, Inc. Common Stock positions in Q4 2019 and 11 closed out, a net change of -9 holders.
  • The largest F-star Therapeutics, Inc. Common Stock buyer in Q4 2019 was Renaissance Technologies, an estimated $162K added.
  • The largest F-star Therapeutics, Inc. Common Stock seller in Q4 2019 was Adage Capital Partners, an estimated $4.9M sold.

Based on aggregated 13F filings for Q4 2019.